Search research articles
Contact Us
Filters
Showing results (621-630 of 845) with videos related to
Page
of 85
Sort By:
AJR. American Journal of Roentgenology
|
September 25, 2013
Utility of diffusional kurtosis imaging as a marker of adverse pathologic outcomes among prostate cancer active surveillance candidates undergoing radical prostatectomy
Andrew B Rosenkrantz, Vinay Prabhu, Eric E Sigmund, et al.
AJR. American Journal of Roentgenology
|
November 23, 2013
Utility of MRI features in differentiation of central renal cell carcinoma and renal pelvic urothelial carcinoma
Natasha E Wehrli, Min Ju Kim, Brent W Matza, et al.
Urologic Oncology
|
July 19, 2017
Influence of renal biopsy results on the management of small kidney cancers in older patients: Results from a population-based cohort
Marc A Bjurlin, Elena B Elkin, Coral L Atoria, et al.
Cancer
|
June 8, 2001
A Phase I/II study of weekly paclitaxel and 3 days of high dose oral estramustine in patients with hormone-refractory prostate carcinoma
A C Ferrari, A Chachoua, H Singh, et al.
Angiology
|
February 21, 2003
Delayed embolization of Amplatzer septal occluder device: an unknown entity--a case report
Puneet K Verma, Shyam K S Thingnam, Anurag Sharma, et al.
Clinical Radiology
|
September 3, 2013
Preliminary experience with a novel method of three-dimensional co-registration of prostate cancer digital histology and in vivo multiparametric MRI
C Orczyk, H Rusinek, A B Rosenkrantz, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
September 24, 2015
Length of capsular contact for diagnosing extraprostatic extension on prostate MRI: Assessment at an optimal threshold
Andrew B Rosenkrantz, Alampady K Shanbhogue, Annie Wang, et al.
Academic Radiology
|
November 11, 2017
3D Registration of mpMRI for Assessment of Prostate Cancer Focal Therapy
Clément Orczyk, Andrew B Rosenkrantz, Artem Mikheev, et al.
Prostate Cancer and Prostatic Diseases
|
July 4, 2007
Adjuvant androgen deprivation therapy augments cure and long-term cancer control in men with poor prognosis, nonmetastatic prostate cancer
N Fleshner, T E Keane, C A Lawton, et al.
Expert Opinion on Investigational Drugs
|
March 1, 2006
Toremifene--a promising therapy for the prevention of prostate cancer and complications of androgen deprivation therapy
Samir S Taneja, Matthew R Smith, James T Dalton, et al.
Page
of 85
Search research articles
Search
Showing results (621-630 of 845) with videos related to
Sort By:
Page
of 85
AJR. American Journal of Roentgenology
|
September 25, 2013
Utility of diffusional kurtosis imaging as a marker of adverse pathologic outcomes among prostate cancer active surveillance candidates undergoing radical prostatectomy
Andrew B Rosenkrantz, Vinay Prabhu, Eric E Sigmund, et al.
AJR. American Journal of Roentgenology
|
November 23, 2013
Utility of MRI features in differentiation of central renal cell carcinoma and renal pelvic urothelial carcinoma
Natasha E Wehrli, Min Ju Kim, Brent W Matza, et al.
Urologic Oncology
|
July 19, 2017
Influence of renal biopsy results on the management of small kidney cancers in older patients: Results from a population-based cohort
Marc A Bjurlin, Elena B Elkin, Coral L Atoria, et al.
Cancer
|
June 8, 2001
A Phase I/II study of weekly paclitaxel and 3 days of high dose oral estramustine in patients with hormone-refractory prostate carcinoma
A C Ferrari, A Chachoua, H Singh, et al.
Angiology
|
February 21, 2003
Delayed embolization of Amplatzer septal occluder device: an unknown entity--a case report
Puneet K Verma, Shyam K S Thingnam, Anurag Sharma, et al.
Clinical Radiology
|
September 3, 2013
Preliminary experience with a novel method of three-dimensional co-registration of prostate cancer digital histology and in vivo multiparametric MRI
C Orczyk, H Rusinek, A B Rosenkrantz, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
September 24, 2015
Length of capsular contact for diagnosing extraprostatic extension on prostate MRI: Assessment at an optimal threshold
Andrew B Rosenkrantz, Alampady K Shanbhogue, Annie Wang, et al.
Academic Radiology
|
November 11, 2017
3D Registration of mpMRI for Assessment of Prostate Cancer Focal Therapy
Clément Orczyk, Andrew B Rosenkrantz, Artem Mikheev, et al.
Prostate Cancer and Prostatic Diseases
|
July 4, 2007
Adjuvant androgen deprivation therapy augments cure and long-term cancer control in men with poor prognosis, nonmetastatic prostate cancer
N Fleshner, T E Keane, C A Lawton, et al.
Expert Opinion on Investigational Drugs
|
March 1, 2006
Toremifene--a promising therapy for the prevention of prostate cancer and complications of androgen deprivation therapy
Samir S Taneja, Matthew R Smith, James T Dalton, et al.
Page
of 85